Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study
Clinical trial NCT03886246 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03886246
- Sponsor
- LEO Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2027-09-30
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.